Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab. [electronic resource]
Producer: 20061102Description: 2736-44 p. digitalISSN:- 0006-4971
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antibody-Dependent Cell Cytotoxicity
- Apoptosis
- Burkitt Lymphoma -- immunology
- Cell Line, Tumor
- Cell Proliferation
- Complement System Proteins -- metabolism
- Cytotoxicity, Immunologic
- Female
- HLA-DR Antigens -- immunology
- Humans
- Immunoglobulin G -- administration & dosage
- Lymphoma -- immunology
- Lymphoma, B-Cell -- immunology
- Mice
- Mice, SCID
- Neoplasm Transplantation
- Rituximab
- Transplantation, Heterologous
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.